Lung Cancer Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older.
- People who have been diagnosed with a cancer-related condition.
- People whose lung cancer (a specific type called non-small cell lung cancer) has spread or is advanced, tests positive for a gene change called ALK, and who have already been treated with one of the newer ALK-blocking medicines as their first ALK treatment — these medicines include alectinib, lorlatinib, brigatinib, or ceritinib.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom there is no available information about the most recent cancer treatment they received.
- People who have not given general or specific consent to take part in this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
A classifier predicting outcome for advanced NSCLC ALK+ patients on ALK inhibitor treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.